Related Experiment Video
Updated: May 9, 2025
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
FEATURES OF VASOMOTOR RHINITIS IN PATIENTS WITH A HISTORY OF COVID-19 INFECTION
N Nakudashvili1, L Ratiani2, T Megrelishvili2
11Tbilisi State Medical University; 2National Center of Otorhinolaryngology, Georgia.
Objective:
to determine some aspects of the pathogenesis of VMR in patients with a history of COVID-19 infection and to evaluate the therapeutic efficacy of a local antihistamine drug.
Design:
Data was collected from patients diagnosed with Vasomotor rhinitis (VMR) (who had COVID-19 more than 6 months ago, group I) and those without COVID-19 (group II). These patients were filtered to seasonal allergens, a history of bronchial asthma and/or bronchial hypersensitivity, chronic rhinosinusitis, nasal polyposis or sensitivity to aspirin, pregnancy, acute phase of COVID-19 infection, and use of anti-inflammatory drugs within the last 6 weeks.
Setting:
First University Clinics of Tbilisi State Medical University and the National Centre of Otorhinolaryngology (Tbilisi, Georgia).
Participants:
Patients diagnosed with VMR for 6 weeks or more were selected.
Methods:
All patients underwent the instrumental (anterior and posterior rhinoscopy, endoscopy, rhinomanometry) examination, the cytological (eosinophils, neutrophils, and leukocytes count), and biochemical investigations of nasal smear (the content of nitric oxide (NO)) and blood serum total antioxidant activity. Patients were treated with intranasal antihistamine spray - 2 sprays 2 times a day for 10 days. All studies were performed on patients before and after treatment.
Results:
No statistically reliable difference in the initial insights of the objective and subjective indicators for groups I and II were detected; the cytological examination of nasal smears showed that in patients from group I eosinophils, lymphocytes, an increased number of neutrophils and low-level of NO were revealed compared to corresponding indicators in patients from group II. The level of TAA in the blood serum of patients with VMR was lower than in healthy volunteers (especially in patients of group I).
Conclusions:
In patients with VMR previously exposed to COVID-19 infection, the intensity of the oxidative stress and depletion of nasal NO were especially high, causing the abolishment of protective ability, chronic eosinophilic inflammation, and airway hyperresponsiveness. Antihistamine spray is effective for VMR treatment in groups I and II; in patients with VMR who previously had a COVID-19 infection, it is necessary to increase the treatment course duration.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
07:36Contact-Free Co-Culture Model for the Study of Innate Immune Cell Activation During Respiratory Virus Infection
Published on: February 28, 2021
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:27Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
01:24Asthma-III: Symptoms and Complications
Classification of Asthma
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:15Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.